--YERSINIA PROTEOME MICROARRAYS

The US Army Medical Research Acquisition Activity (USAMRAA) intends to negotiate, on a sole source basis, under authority of 41 U.S.C. 253(c), with Invitrogen to further work performed in printing, quality control and delivering 250 high-content microarrays consisting of proteins representative of over 70% of the predicted Yersinia pestis proteome. Services are required for the USA Med Research Institute of Infectious Diseases (USAMRIID) at for Detrick in support of project TMTITA2FY06070. Invitrogen is uniquely qualified to meet the Governments need due to its technical knowledge of the requirement and personnel familiarity with project TMTITA2FY06070. By working with Invitrogen compromising the science is avoided. The period of performance will be six months, with work to be performed at the USAMRIID, Fort Detrick, MD facility. No solicitation package will be issued. This notice of intent is not a request for competitive quotations. However, responses received by September 24, 2008, will be considered by the Government. A determination by the Government not to compete the proposed acquisition based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a future competitive procurement.